Risk factors associated with cognitive decline in the elderly with type 2 diabetes: Pooled logistic analysis of a 6-year observation in the Japanese elderly diabetes intervention trial

Geriatrics and Gerontology International

Volumn 12, Issue SUPPL.1, 2012, Pages 110-116

  Umegaki, Hiroyuki ^a   Iimuro, Satoshi ^b   Shinozaki, Tomohiro ^b   Araki, Atsushi ^c   Sakurai, Takashi ^b,d   Iijima, Katsuya ^e,f   Ohashi, Yasuo ^b   Ito, Hideki ^c,d  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Tokyo Metropolitan Institute of Gerontology   (Japan)

^e NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diastolic blood pressure; Glycated hemoglobin A1c; High density lipoprotein cholesterol; Mini Mental State Examination

Indexed keywords

HEMOGLOBIN A1C; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; BLOOD PRESSURE; COGNITIVE DEFECT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; JAPANESE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

AGED; BLOOD GLUCOSE; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPID A; LOGISTIC MODELS; MALE; RISK FACTORS;

EID: 84858770438     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2011.00818.x     Document Type: Article

References (42)

1. Ryan CM, Geckle MO. Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care 2000; 23: 1486-1493.
2. Dey J, Misra A, Desai NG, Mahapatra AK, Padma MV. Cognitive function in younger type II diabetes. Diabetes Care 1997; 20: 32-35.
3. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 2004; 26: 1044-1080.
4. Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999; 16: 93-112.
5. Cukierman-Yaffe T, Gerstein HC, Williamson JD etal. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators. Diabetes Care 2009; 32: 221-226.
6. Gregg EW, Mangione CM, Cauley JA etal. Diabetes and incidence of functional disability in older women. Diabetes Care 2002; 25: 61-67.
7. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 2004; 164: 1327-1333.
8. van den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kappelle LJ, Biessels GJ. A 4year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Utrecht Diabetic Encephalopathy Study Group. Diabetologia 2010; 53: 58-65.
9. Standards of Medical Care in Diabetes. American Diabetes Association. Diabetes Care 2010; 33: S11-S61.
10. Hassing LB, Hofer SM, Nilsson SE etal. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 2004; 33: 355-361.
11. Ito H. Japanese Elderly Diabetes Intervention Trial (J-EDIT). Nippon Rinsho 2006; 64: 21-26.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method of grading the cognitive function of patients or the clinician. J Psychiatr Res 1978; 12: 189-198.
13. Yesavage JA. The use of self-rating depression scales in the elderly. In: Poon LW, ed. Clinical Memory Assessment of Older Adults. Washington DC: American Psychological Association, 1986; 213-217.
14. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2007; 30: S42-S47.
15. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 2010; 53: 450-467.
16. Gustafson DR, Skoog I, Rosengren L, Zetterberg H, Blennow K. Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women. J Neurol Neurosurg Psychiatry 2007; 78: 461-464.
17. Cupples LA, D'Agostino RB, Anderson K, Kannel WB. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med 1988; 7: 205-218.
18. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham heart study. Stat Med 1990; 9: 1501-1515.
19. Umegaki H, Iimuro S, Shinozaki T etal. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: Baseline data analysis of the Japanese elderly diabetes intervention trial. Geriatr Gerontol Int 2012; 12 (Suppl. 1): 103-109.
20. Jorm AF. Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000; 46: 219-227.
21. Umegaki H, Iimuro S, Kaneko T etal. Factors associated with lower Mini Mental State Examination scores in elderly Japanese diabetes mellitus patients. Neurobiol Aging 2008; 29: 1022-1026.
22. Raffaitin C, Féart C, Le Goff M etal. Metabolic syndrome and cognitive decline in French elders: the Three-City Study. Neurology 2011; 76: 518-525.
23. van Exel E, de Craen AJ, Gussekloo J etal. Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol 2002; 51: 716-721.
24. Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol 2008; 28: 1556-1562.
25. Raber J, Huang Y, Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 2004; 25: 641-650.
26. Hoshino T, Kamino K, Matsumoto M. Gene dose effect of the APOE-epsilon4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease. Neurobiol Aging 2002; 23: 41-45.
27. Raygani AV, Rahimi Z, Kharazi H, Tavilani H, Pourmotabbed T. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease. Neurosci Lett 2006; 408: 68-72.
28. de la Torre JC. Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol Res 2004; 26: 517-524.
29. Schneider JA, Bienias JL, Wilson RS, Berry-Kravis E, Evans DA, Bennett DA. The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. Stroke 2005; 36: 954-959.
30. Saidi S, Slamia LB, Ammou SB, Mahjoub T, Almawi WY. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels. J Stroke Cerebrovasc Dis 2007; 16: 60-66.
31. Ward MA, Bendlin BB, McLaren DG etal. Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. Front Aging Neurosci 2010; 2: 29.
32. Akisaki T, Sakurai T, Takata T etal. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 2006; 22: 376-384.
33. de Leeuw FE, de Groot JC, Oudkerk M etal. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999; 46: 827-833.
34. den Heijer T, Launer LJ, Prins ND etal. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 2005; 64: 263-267.
35. Tsivgoulis G, Alexandrov AV, Wadley VG etal. Association of higher diastolic blood pressure levels with cognitive impairment. Neurology 2009; 73: 589-595.
36. Cacciatore F, Abete P, Ferrara N etal. The role of blood pressure in cognitive impairment in an elderly population. Osservatorio Geriatrico Campano Group. J Hypertens 1997; 15: 135-142.
37. Stone MA, Wilkinson JC, Charpentier G etal. Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries. GUIDANCE Study Group. Diabetes Res Clin Pract 2010; 87: 252-260.
38. Qiu C, Winblad B, Fratiglioni L. Low diastolic pressure and risk of dementia in very old people: a longitudinal study. Dement Geriatr Cogn Disord 2009; 28: 213-219.
39. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003; 61: 1667-1672.
40. van Dijk EJ, Breteler MM, Schmidt R etal. CASCADE Consortium. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 2004; 44: 625-630.
41. den Heijer T, Launer LJ, Prins ND etal. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 2005; 64: 263-277.
42. Christman AL, Matsushita K, Gottesman RF etal. Glycatedhaemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetologia 2011; 54: 1645-1652. doi: 10.1007/s00125-011-2095-7.